Summary & Overview
HCPCS S4991: Nicotine Patches, Non-Legend
HCPCS Level II code S4991 denotes non-legend nicotine patches used as nicotine replacement therapy for tobacco cessation. Nationally, coverage and reimbursement for over-the-counter nicotine replacement products influence access to smoking cessation interventions, public health outcomes, and pharmacy benefit management. Payers often establish specific coverage policies or prior authorization rules that affect utilization and patient out-of-pocket costs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and service settings, payer coverage considerations, and common billing modifiers associated with HCPCS supply codes. The publication outlines benchmark concepts and policy update areas relevant to nicotine replacement therapy reimbursement, including coverage criteria, billing practice implications, and documentation points important for claims processing. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code S4991 represents nicotine patches, non-legend. This code describes a tobacco cessation product delivered as a transdermal patch designed to provide controlled doses of nicotine for use in smoking cessation programs.
Service type: Durable medical supply / over-the-counter nicotine replacement therapy
Typical site of service: Retail pharmacy, outpatient clinic, or home use
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient who uses combustible tobacco presents to a primary care clinic seeking assistance with smoking cessation. After a counseling session and review of contraindications, the clinician determines nicotine replacement therapy is appropriate and prescribes over-the-counter transdermal nicotine patches supplied by the clinic for a short-term quit attempt. The clinical workflow includes: initial assessment of tobacco use and readiness to quit, review of medical history (including recent myocardial infarction, pregnancy, or dermatologic sensitivities), counseling and documentation of quit plan, prescription or provision of S4991 nicotine patches, and scheduling follow-up or referral to a tobacco cessation program. Nursing documents patch supply lot, patch strength, application instructions, and adverse skin reactions. Pharmacy or clinic staff counsel on patch rotation, timing, and step-down dosing. Follow-up visits assess effectiveness, side effects, and need for alternative pharmacotherapy or behavioral support.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional clinical effort beyond typical counseling or documentation is required (e.g., complex medical review or management accompanying patch provision). |